OBI Pharma (ROCO:4174) Beginning Cash Position : NT$1,732.05 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is OBI Pharma Beginning Cash Position?

OBI Pharma's Beginning Cash Position for the quarter that ended in Mar. 2025 was NT$1,732.05 Mil.

OBI Pharma's quarterly Beginning Cash Position declined from Sep. 2024 (NT$1,120.64 Mil) to Dec. 2024 (NT$684.79 Mil) but then increased from Dec. 2024 (NT$684.79 Mil) to Mar. 2025 (NT$1,732.05 Mil).

OBI Pharma's annual Beginning Cash Position increased from Dec. 2022 (NT$2,512.19 Mil) to Dec. 2023 (NT$4,741.11 Mil) but then declined from Dec. 2023 (NT$4,741.11 Mil) to Dec. 2024 (NT$899.28 Mil).

OBI Pharma Beginning Cash Position Historical Data

The historical data trend for OBI Pharma's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OBI Pharma Beginning Cash Position Chart

OBI Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

4,860.02

3,338.30

2,512.19

4,741.11

899.28

OBI Pharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															899.28	1,282.07	1,120.64	684.79	1,732.05

OBI Pharma Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

OBI Pharma Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of OBI Pharma's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

OBI Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OBI Pharma Inc (ROCO:4174) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhongxiao E Road, 6th Floor, No. 508, Section 7, Nangang District, Taipei, TWN, 115

Website

https://www.obipharma.com

OBI Pharma Inc is engaged in new drugs research of novel cancer therapeutic agents for patients with unmet medical needs. The company has four reportable segments, which are anti-cancer new drug segment, bispecific monoclonal antibody new drug segment, botulinum toxin new drug segment and CDMO segment.

OBI Pharma Headlines

No Headlines